SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-209842
Filing Date
2020-08-05
Accepted
2020-08-05 07:07:33
Documents
14
Period of Report
2020-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d156551d8k.htm   iXBRL 8-K 26013
2 EX-99.1 d156551dex991.htm EX-99.1 604178
6 GRAPHIC g156551g38t81.jpg GRAPHIC 5510
  Complete submission text file 0001193125-20-209842.txt   815535

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20200803.xsd EX-101.SCH 3083
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20200803_lab.xml EX-101.LAB 18838
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20200803_pre.xml EX-101.PRE 11847
7 EXTRACTED XBRL INSTANCE DOCUMENT d156551d8k_htm.xml XML 3603
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 201075593
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences